Table 1.
Baseline characteristics | VUGIB = 28,275 |
NVUGIB = 781,369 |
||||
---|---|---|---|---|---|---|
Nontransferred (n = 24,744) | Transferred (n = 2887) | P value | Nontransferred (n = 684,136) | Transferred (64,969) | P value | |
Age: mean (95% CI) (years) | 57.59 (57.23–57.95) |
56.63 (55.53–57.73) |
0.07 | 67.07 (66.97–67.17) |
66.66 (66.38–66.94) |
<0.01 |
Female gender, % | 35.73 | 32.7 | 0.36 | 45.63 | 42.99 | <0.01 |
Race, % | < 0.01 | < 0.01 | ||||
White | 67.99 | 81.66 | 70.63 | 81.74 | ||
Black | 7.93 | 3.55 | 15.38 | 10.12 | ||
Hispanic | 20.38 | 13.41 | 10.03 | 6.13 | ||
Asians | 3.70 | 1.38 | 3.96 | 2.01 | ||
Charlson’s comorbidity index, % | 0.64 | < 0.01 | ||||
1 | 2.34 | 2.61 | 26.34 | 22.17 | ||
2 | 1.55 | 0.87 | 20.04 | 19.33 | ||
≥3 | 96.11 | 96.52 | 53.62 | 58.5 | ||
Median household income in the patient’s zip code (quartile), % | < 0.01 | < 0.01 | ||||
1st (0–25th) | 31.08 | 38.05 | 29.55 | 38.22 | ||
2nd (26th–50th) | 27.08 | 31.68 | 26.18 | 33.19 | ||
3rd (51st–75th) | 24.32 | 20.18 | 24.29 | 18.48 | ||
4th (76th–100th) | 17.53 | 10.09 | 19.98 | 10.11 | ||
Insurance status, % | 0.01 | < 0.01 | ||||
Medicare | 35.91 | 39.82 | 64.51 | 66.51 | ||
Medicaid | 26.79 | 26.79 | 12.41 | 12 | ||
Private | 28.29 | 25.69 | 18.45 | 17.35 | ||
Uninsured | 9.03 | 7.71 | 4.64 | 4.14 | ||
Hospital region, % | < 0.01 | < 0.01 | ||||
Northeast | 15.32 | 14.43 | 16.77 | 11.76 | ||
Midwest | 19.4 | 31.13 | 21.02 | 31.97 | ||
South | 40.15 | 34.78 | 40.34 | 36.59 | ||
West | 25.13 | 19.65 | 21.87 | 19.68 | ||
Hospital bed size, % | < 0.01 | < 0.01 | ||||
Small | 19.77 | 10.26 | 21.53 | 12.99 | ||
Medium | 32.31 | 26.26 | 31.32 | 25.19 | ||
Large | 47.92 | 63.48 | 47.16 | 61.82 | ||
Hospital location, % | < 0.01 | < 0.01 | ||||
Rural | 6.62 | 6.26 | 7.78 | 5.74 | ||
Urban | 93.38 | 93.74 | 92.22 | 94.26 | ||
Thrombocytopenia, % | 38.68 | 42.43 | 0.2 | 8.6 | 11.15 | <0.01 |
Anticoagulant use, % | 4.08 | 5.39 | 0.05 | 14.55 | 14.16 | <0.01 |
End-stage renal disease, % | 2.42 | 2.09 | 0.8 | 6.25 | 6.72 | <0.01 |
Obesity, % | 12.87 | 15.3 | 0.1 | 14.12 | 15.95 | <0.01 |
Coagulopathy, % | 2.54 | 3.13 | 0.13 | 8.43 | 10.86 | <0.01 |
NVUGIB indicates nonvariceal upper GI bleed; VUGIB, nonvariceal upper GI bleed.